511 Therapeutics, Inc. — Form D
511 Therapeutics, Inc. of CAMBRIDGE, MA, a company, filed a Form D exempt-offering notice with the SEC on 2022-10-06. The offering totals $600K, of which $50K was reported sold. Industry: Biotechnology.
Offering
- Filed: 2022-10-06
- Form: D
- Accession: 0001946264-22-000001
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $600K
- Amount sold: $50K
- Remaining: $550K
- Investors: 1
- Date of first sale: 2022-09-23
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-461019
Issuer
- Name: 511 Therapeutics, Inc.
- CIK: 0001946264
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2022
- Address: 1770 MASSACHUSETTS AVENUE, CAMBRIDGE, MA, 02140
- Phone: (617) 818-7126
Officers, directors & promoters (4)
| Name | Role | Location |
|---|
| Yancen Lu | Director | CAMBRIDGE, MA |
| Uwe B Sleytr | Director | CAMBRIDGE, MA |
| Shuguang Zhang | Director | CAMBRIDGE, MA |
| Shuguang Zhang | Executive Officer | CAMBRIDGE, MA |
More